The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial.
about
'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?Stem cell transplantation for acute myelocytic leukaemia in paediatric patients in first remissionStem cell transplantation for acute myelocytic leukaemia in paediatric patients in first remissionRisk factors for relapse after allogeneic transplantation in acute myeloid leukemiaCore Binding Factor Acute Myeloid Leukemia: New Prognostic Categories and Therapeutic OpportunitiesHow I treat pediatric acute myeloid leukemiaAllogeneic stem cell transplantation in first complete remissionChildhood acute myeloid leukaemiaProgress in acute myeloid leukemiaCharacteristics predicting outcomes of allogeneic stem-cell transplantation in relapsed acute myelogenous leukemia.Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemia.The effect of equine antithymocyte globulin on the outcomes of reduced intensity conditioning for AML.Hematopoietic stem cell transplantation for leukemiaOutcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia.Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial.Survival is poorer in patients with secondary core-binding factor acute myelogenous leukemia compared with de novo core-binding factor leukemia.Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.Myeloablative conditioning regimens for AML allografts: 30 years later.Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research studyEfficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate-Risk Acute Myeloid Leukemia Adult Patients in First Complete Remission: A Meta-Analysis of Prospective StudiesAdult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature.The role of allogeneic transplantation in high-risk acute myelogenous leukemia.Postremission therapy for children with acute myeloid leukemia: the children's cancer group experience in the transplant era.Autologous stem cell transplantation in the treatment of adults with acute myeloid leukaemia.The treatment of AML: current status and novel approaches.Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patientsAutologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation ResearchGuidelines on the management of acute myeloid leukaemia in adults.HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR.Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States.Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML.Hematopoietic transplantation from adult unrelated donors as treatment for acute myeloid leukemia.Reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.Use of biological assignment in hematopoietic stem cell transplantation clinical trials.How we approach patient evaluation for hematopoietic stem cell transplantation.Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia.Allogeneic stem cell transplant in adult patients with acute myelogenous leukemia: a systematic analysis of international guidelines and recommendations.Role of allogeneic transplantation for FLT3/ITD acute myeloid leukemia: outcomes from 133 consecutive newly diagnosed patients from a single institution.Analysis of efficacy and cost-effectiveness of high-dose arabinoside versus daunorubicin chemotherapy in older adult patients with acute myeloid leukemia by cytogenetic risk profile: retrospective review from China.
P2860
Q22066036-2F299E56-5E2A-47DF-A269-97DDCAD15D36Q24197549-F6EE00CD-CE38-458E-A470-0AEFDB97F11CQ24244641-63090E37-415A-4CA8-B724-9221BC11729EQ26771438-1E986E1A-52E1-466C-8C92-76612452D499Q26863756-F0E28B89-B7DB-4984-A4EE-7720D706DE09Q26992280-94DA7324-CE6F-46DA-B1A3-E081C268F282Q26996818-E9B43188-5D02-4983-A450-4D042557784DQ27005960-E36923A7-0626-46E4-9A85-282AC3B809DAQ27024006-106B4BB1-A6C4-495C-96D6-5CB7E0BDE0CEQ33611146-C39B235B-EB84-47FE-A66B-E011CC9FA4E2Q33680218-1CB478E3-D6BF-4456-BC85-64D5D4E9E029Q33797194-4150D92D-D2AF-4580-87E3-D6DA1511EB22Q34034180-283A50F5-6FEE-45F1-81C7-4AE5305F67E3Q34079823-7DDD682B-055A-42E7-A63F-AE7675C13F0DQ34166581-F5E93DE4-9FE0-4C8D-9BC5-9AB5A0C1C699Q34285901-88884DF0-2028-4F51-9BE2-4BF71B7802C1Q34505185-216ECBFB-927C-4DB0-AD3B-C1A723FE1F81Q35561038-92EF2C37-D7E2-443F-A6D1-F8694C53D944Q35574536-B2CD903A-C617-403C-B249-15A1EC292511Q35574597-4CE49405-A4EF-4E59-ABA4-B97C05EF11E0Q35703480-C8BE3D3F-C370-4D8B-A9F4-0C40B9C651BEQ35887901-C4A132BD-1E96-4E2A-9A58-CB7BBD465EEDQ35903540-3950428C-4FF2-418A-8051-447AC72D4E88Q36097750-20A7480E-EFF5-49CA-9CEC-930B25279B05Q36255287-E27911F8-EA2D-47C2-8C07-2B9435644275Q36269943-169972F9-FAC2-41BE-8996-71DEB0707BAFQ36337955-55450B1B-BCA0-4B06-B9B1-56E9B3EE0676Q36579065-16700E80-2DB6-4EED-BF31-143864A69CCAQ36630107-F15E3B69-14C1-46FE-989F-5A3A745CDD23Q36865630-9657EEA1-EB57-4496-A3E2-7FAA309BB2F6Q37051052-87FDC295-CDB0-4A2D-AB5C-2FA5154CC037Q37061964-DBAE30F1-2977-4C13-B135-5C6FBCE6C2E0Q37061969-8950CB5B-3E59-481B-B504-3FD41F017EFEQ37159533-9773BE58-DB23-4FCB-9FD1-65EF09C85DC9Q37163399-791BA5D0-5254-489C-B0AA-0E697D553A9EQ37755957-0460520F-3FB2-4847-AFF7-B1422DE659CEQ37810123-9C1A2445-E4E0-444C-BB50-02DEA5AAA547Q37842488-D782513C-4D14-45D8-9BCD-CA44CAA0C224Q37842861-D84CEA23-403B-490B-8E5C-F3E219C91FDDQ37851038-6E14A42A-CBC5-4B6D-80F8-2DBB6B495AF5
P2860
The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The value of allogeneic bone m ...... ts of the UK MRC AML 10 trial.
@ast
The value of allogeneic bone m ...... ts of the UK MRC AML 10 trial.
@en
The value of allogeneic bone m ...... ts of the UK MRC AML 10 trial.
@nl
type
label
The value of allogeneic bone m ...... ts of the UK MRC AML 10 trial.
@ast
The value of allogeneic bone m ...... ts of the UK MRC AML 10 trial.
@en
The value of allogeneic bone m ...... ts of the UK MRC AML 10 trial.
@nl
prefLabel
The value of allogeneic bone m ...... ts of the UK MRC AML 10 trial.
@ast
The value of allogeneic bone m ...... ts of the UK MRC AML 10 trial.
@en
The value of allogeneic bone m ...... ts of the UK MRC AML 10 trial.
@nl
P2093
P2860
P921
P1476
The value of allogeneic bone m ...... ts of the UK MRC AML 10 trial.
@en
P2093
Alan K Burnett
Anthony H Goldstone
Georgina Harrison
Ian M Hann
John H K Rees
Keith Wheatley
Medical Research Council Adult and Paediatric Working Parties
Richard F Stevens
P2860
P304
P356
10.1046/J.1365-2141.2002.03724.X
P407
P577
2002-08-01T00:00:00Z